We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
60 hedge funds and large institutions have $33.8M invested in Zevra Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
225% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 8
0.59% more ownership
Funds ownership: 17.16% → 17.75% (+0.59%)
7% less call options, than puts
Call options by funds: $2.32M | Put options by funds: $2.51M
14% less funds holding
Funds holding: 70 → 60 (-10)
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
92% less capital invested
Capital invested by funds: $404M → $33.8M (-$370M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
60
Holders Change
-10
Holders Change %
-14.29%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
26
Reduced
8
Closed
14
Calls
$2.32M
Puts
$2.51M
Net Calls
-$188K
Net Calls Change
-$130K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.84M |
| 2 |
Jane Street
New York
|
+$809K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$374K |
| 4 |
Millennium Management
New York
|
+$337K |
| 5 |
Morgan Stanley
New York
|
+$200K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$411K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$321K |
| 3 |
Man Group
London,
United Kingdom
|
-$175K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$139K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$138K |
